Literature DB >> 33801427

Using the Updated EWGSOP2 Definition in Diagnosing Sarcopenia in Spanish Older Adults: Clinical Approach.

Anna Arnal-Gómez1,2, Maria A Cebrià I Iranzo1,3,4, Jose M Tomas5,6, Maria A Tortosa-Chuliá7,8, Mercè Balasch-Bernat1,4, Trinidad Sentandreu-Mañó1,6, Silvia Forcano3, Natalia Cezón-Serrano1,4.   

Abstract

Recently the European Working Group on Sarcopenia in Older People (EWGSOP2) has updated diagnostic criteria for sarcopenia, which consist of one or more measures of muscle strength, muscle mass, and physical performance, plus an initial screening test called SARC-F. The main objective was to compare the number of cases of sarcopenia, using the different measurements and screening options. A cross-sectional study was conducted on Spanish older adults (n = 272, 72% women). Combining the different measures proposed by the steps described in the EWGSOP2 algorithm, 12 options were obtained (A-L). These options were studied in each of the three models: (1) using SARC-F as initial screening; (2) not using SARC-F; and (3) using SARC-CalF instead of SARC-F. A χ2 independence test was statistically significant (χ2(6) = 88.41, p < 0.001), and the association between the algorithm used and the classification of sarcopenia was moderate (Cramer's V = 0.226). We conclude that the different EWGSOP2 measurement options imply case-finding differences in the studied population. Moreover, when applying the SARC-F, the number of people classified as sarcopenic decreases. Finally, when SARC-CalF is used as screening, case finding of sarcopenic people decreases. Thus, clinical settings should consider these outcomes, since these steps can make preventive and therapeutic interventions on sarcopenia vary widely.

Entities:  

Keywords:  clinical; diagnostic criteria; older adults; sarcopenia

Year:  2021        PMID: 33801427      PMCID: PMC7958601          DOI: 10.3390/jcm10051018

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  52 in total

1.  Functional outcomes for clinical trials in frail older persons: time to be moving.

Authors: 
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-02       Impact factor: 6.053

2.  Gait speed and survival in older adults.

Authors:  Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

3.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

4.  A 30-s chair-stand test as a measure of lower body strength in community-residing older adults.

Authors:  C J Jones; R E Rikli; W C Beam
Journal:  Res Q Exerc Sport       Date:  1999-06       Impact factor: 2.500

5.  Screening for Frailty and Sarcopenia Among Older Persons in Medical Outpatient Clinics and its Associations With Healthcare Burden.

Authors:  Li Feng Tan; Zhen Yu Lim; Rachel Choe; Santhosh Seetharaman; Reshma Merchant
Journal:  J Am Med Dir Assoc       Date:  2017-02-24       Impact factor: 4.669

6.  Prevalence of sarcopenia and associated factors in institutionalised older adult patients.

Authors:  Patricia Bravo-José; Elena Moreno; Minerva Espert; María Romeu; Pilar Martínez; Concepción Navarro
Journal:  Clin Nutr ESPEN       Date:  2018-06-02

7.  Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status.

Authors:  M J Kaiser; J M Bauer; C Ramsch; W Uter; Y Guigoz; T Cederholm; D R Thomas; P Anthony; K E Charlton; M Maggio; A C Tsai; D Grathwohl; B Vellas; C C Sieber
Journal:  J Nutr Health Aging       Date:  2009-11       Impact factor: 4.075

8.  Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria.

Authors:  J Chew; A Yeo; S Yew; J P Lim; L Tay; Y Y Ding; W S Lim
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

9.  The timed "Up & Go": a test of basic functional mobility for frail elderly persons.

Authors:  D Podsiadlo; S Richardson
Journal:  J Am Geriatr Soc       Date:  1991-02       Impact factor: 5.562

10.  Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity.

Authors:  Satoshi Ida; Kazuya Murata; Daiki Nakadachi; Yuki Ishihara; Kanako Imataka; Akihiro Uchida; Kou Monguchi; Ryutaro Kaneko; Ryoko Fujiwara; Hiroka Takahashi
Journal:  Aging Clin Exp Res       Date:  2016-11-10       Impact factor: 3.636

View more
  4 in total

1.  30 s sit-to-stand power is positively associated with chest muscle thickness in COVID-19 survivors.

Authors:  Rodrigo Núñez-Cortés; Carlos Cruz-Montecinos; Francisco Martinez-Arnau; Rodrigo Torres-Castro; Esteban Zamora-Risco; Sofía Pérez-Alenda; Lars L Andersen; Joaquín Calatayud; Estanislao Arana
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

2.  Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease.

Authors:  Naiade Silveira Almeida; Raquel Rocha; Claudineia Almeida de Souza; Ana Carolina Sirelli da Cruz; Bruna Dos Reis Ribeiro; Luiza Valois Vieira; Carla Daltro; Rafael Silva; Manoel Sarno; Helma Pinchemel Cotrim
Journal:  World J Hepatol       Date:  2022-08-27

3.  Muscle Weakness and Walking Slowness for the Identification of Sarcopenia in the Older Adults from Northern Brazil: A Cross-Sectional Study.

Authors:  Alex Barreto de Lima; Duarte Henrinques-Neto; Gustavo Dos Santos Ribeiro; Elvio Rúbio Gouveia; Fátima Baptista
Journal:  Int J Environ Res Public Health       Date:  2022-07-29       Impact factor: 4.614

4.  Impact of Using Population-Specific Cut-Points, Self-Reported Health, and Socio-Economic Parameters to Predict Sarcopenia: A Cross-Sectional Study in Community-Dwelling Kosovans Aged 60 Years and Older.

Authors:  Arben Boshnjaku; Abedin Bahtiri; Kaltrina Feka; Ermira Krasniqi; Harald Tschan; Barbara Wessner
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.